Biotech · Private company · Kings Park, NY, US
Cmtx Biotech, Inc.
Track this companyFree. Adds Cmtx Biotech, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- Drug Repurposing for the Treatment of Staphylococcus aureus BacteremiaFiscal year 2026 · $296.5KNIH RePORTER 1R41AI197642-01 · fetched Nov 12, 2026
- Novel Small Molecule for the Prevention of Hemorrhagic CystitisFiscal year 2026 · $349.7KNIH RePORTER 1R41DK143771-01A1 · fetched Nov 12, 2026
- A Lung-Specific, Sulfonium Lipid Nanoparticle (sLNP) Formulation of Incyclinide for the Treatment of ALI/ARDSFiscal year 2026 · $368KNIH RePORTER 1R41HL184801-01A1 · fetched Nov 12, 2026
- Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress SyndromeFiscal year 2025 · $887.4KNIH RePORTER 4R42HL166050-02 · fetched Nov 12, 2026
- A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung InjuryFiscal year 2025 · $295.7KNIH RePORTER 5R41AI187083-02 · fetched Nov 12, 2026
- A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung InjuryFiscal year 2024 · $300KNIH RePORTER 1R41AI187083-01 · fetched Nov 12, 2026